Answers are grounded in this paper and cite their sources.
The ketolide HMR 3647 (previously RU 66647) was evaluated against 2, 563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.
No takes yet. Share an insight, caveat, or question.
Barry et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: